K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Olivier Hermine
also known as Hermine O, Hermine, O, Hermine, O.
Hôpital Necker-Enfants Malades · Centre National de la Recherche Scientifique · Inserm · Université Paris Cité
About this author
Works
1,805
Cited by
64,966
h-index
135
i10
780
ORCID ↗
Top papers
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie, Nicole Brousse, Anne‐Marie Bouvier, et al.
·
2009
·
The Lancet
↗ 1,088
Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection
Olivier Hermine, François Lefrère, Jean–Pierre Bronowicki, et al.
·
2002
·
New England Journal of Medicine
↗ 798
OA
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux, et al.
·
2020
·
JAMA Internal Medicine
↗ 774
OA
Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria
Peter Valent, Cem Akin, Luís Escribano, et al.
·
2007
·
European Journal of Clinical Investigation
↗ 744
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Dreyling, Elı́as Campo, Olivier Hermine, et al.
·
2017
·
Annals of Oncology
↗ 733
OA
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
Alexis A. Thompson, Mark C. Walters, Janet L. Kwiatkowski, et al.
·
2018
·
New England Journal of Medicine
↗ 654
OA
Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting
Kunihiro Tsukasaki, Olivier Hermine, Ali Bazarbachi, et al.
·
2008
·
Journal of Clinical Oncology
↗ 549
OA
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
Arnaud Jaccard, Philippe Moreau, Véronique Leblond, et al.
·
2007
·
New England Journal of Medicine
↗ 515
Treatment of Older Patients with Mantle-Cell Lymphoma
Hanneke C. Kluin‐Nelemans, Eva Hoster, Olivier Hermine, et al.
·
2012
·
New England Journal of Medicine
↗ 515
OA
Transforming Growth Factor β1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans Cells
Frédéric Geissmann, Cathérine Prost, Jean‐Paul Monnet, et al.
·
1998
·
The Journal of Experimental Medicine
↗ 499
OA
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Jason Gotlib, Hanneke C. Kluin‐Nelemans, Tracy I. George, et al.
·
2016
·
New England Journal of Medicine
↗ 470
OA
ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
D. S. Petrov, Colin D. Mansfield, Alain Moussy, et al.
·
2017
·
Frontiers in Aging Neuroscience
↗ 437
OA